Parkinson's DiseaseNCT07772622
The Validity and Reliability of an Improved Paper Grasping Test for Parkinson's Disease
An observational study of Parkinson's Disease and Validity, run by Sanko University at 1 site in Turkey (Türkiye).
Trial summary
The study will include volunteer patients diagnosed with Parkinson's disease who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital. Patients who meet the inclusion criteria will be evaluated by Dr. Read more about this study
- Who is it for?
- Ages 40 to 65 years
- Conditions the study is for
- Parkinson's Disease, Validity, Reability
- How many people
- 40 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 10 Aug 2025to 25 Jun 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: parkinson
Inclusion Criteria:Individuals aged between 18 and 65 years who have been diagnosed with Parkinson's disease
Individuals who voluntarily agree to participate in the study -
Exclusion Criteria:Individuals who are pregnant or within the first three months postpartum
Individuals who have taken any medication affecting walking ability within the last month or who have experienced an orthopedic injury within the last month
-
Trial locations and contacts
1 site in 1 country.
About this study
The study will include volunteer patients diagnosed with Parkinson's disease who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital.
Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University.
Read more
The assessment form prepared by the researchers will be completed face-to-face with the patients. First, demographic information and disease-related data (duration since Parkinson's diagnosis, disease stage, affected side, etc.) will be recorded. The Mini-BESTest will be used to evaluate balance and gait. The muscle strength of the ankle plantar flexor and dorsiflexor muscles will be assessed using a manual muscle testing device, and quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Since fall problems in patients may be related to balance impairments, lower limb muscle weakness, and reduced quality of life, these parameters will also be evaluated. Therefore, in this study, while examining the validity and reliability of the modified paper grip test in individuals with Parkinson's disease, its correlation with these parameters will also be investigated.
Before administering the tests, participants will receive a practical explanation of how the tests are performed and will be allowed to rest prior to assessment. The tests will be administered in the following order: first, the paper grip test by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle plantar and dorsiflexor muscle strength, and evaluation of quality of life.
One week after the initial assessment, only the paper grip test will be re-administered by Physiotherapist Fatma Yılmaz in the same environment. This approach will minimize the effect of environmental factors on the patients' performance.
Read the detailed description
Parkinson's disease is one of the most significant neurodegenerative disorders causing disability worldwide. It is characterized by progressive loss of dopaminergic neurons in the substantia nigra, leading to motor symptoms such as bradykinesia, rigidity, tremor, postural instability, and gait disturbances. Symptoms vary depending on disease stage and the affected neural pathways. Common symptoms observed in individuals with Parkinson's disease include muscle weakness, reduced upper limb function, gait difficulties, balance and coordination impairments, and, in some cases, cognitive and communication problems.
Patients with Parkinson's disease are at high risk of falling, particularly due to balance and postural instability. Consequently, fear of falling can lead to kinesiophobia (fear of movement), decreased engagement in activities of daily living, and difficulties in functional adaptation. Balance problems are among the primary motor deficits in Parkinson's disease and contribute significantly to gait disturbances, postural instability, and fall risk. Therefore, balance rehabilitation is a key focus in the management of Parkinson's disease, especially for fall prevention.
A detailed assessment of balance is essential for planning effective rehabilitation programs. According to the literature, balance evaluation in Parkinson's patients is generally performed using static and dynamic assessments. Commonly used tools include the Mini-BESTest, the Functional Reach Test, and the Timed Up and Go Test (TUG). However, a major contributor to balance problems is lower extremity muscle weakness, particularly in the ankle. While research shows a significant relationship between lower limb muscle weakness and increased fall risk in Parkinson's patients, existing assessment tools often lack direct quantitative measurements, which may reduce their clinical effectiveness.
The Enhanced Paper Grip Test (EPGT) can help address this gap. The EPGT provides a simple measurement of hallux plantar flexion strength without requiring specialized equipment. It can be used to assess fall risk in individuals with Parkinson's disease and has been suggested as a practical screening tool in geriatric populations. The validity and reliability of the test have also been demonstrated in individuals diagnosed with multiple sclerosis. The EPGT is easy to administer, requires minimal space, is low-cost, and quick to perform, making it a practical clinical tool. In this study, the researchers aimed to examine the validity and reliability of the modified paper grip test in Parkinson's patients.
Volunteer patients diagnosed with Parkinson's disease who applied to the SANKO University Sani Konukoğlu Application and Research Hospital Neurology Polyclinic will be included in the study. Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University. The role of Associate Professor Zekiye İpek Kırmacı in the study includes planning the study, formulating hypotheses, interpreting the results, and preparing the manuscript for publication.
The assessment form prepared by the researchers will be completed face-to-face with patients. First, demographic information and disease-related data (such as disease duration, affected side, and affected limb) will be recorded. Balance and gait will be assessed using the Mini-BESTest. The muscle strength of the ankle plantar and dorsiflexor muscles will be measured using a manual muscle testing device, and quality of life will be evaluated with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Because fall risk in Parkinson's patients may be related to balance impairments, lower limb muscle weakness, particularly in the ankle, and reduced quality of life, these parameters will also be examined. Therefore, in this study, while evaluating the validity and reliability of the modified paper grip test in Parkinson's patients, its correlation with these parameters will also be investigated.
Before administering the tests, participants will receive a practical explanation of the procedures and will be allowed to rest prior to assessment. The order of testing will be as follows: first, the paper grip test performed by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle muscle strength, and evaluation of quality of life.
- Conditions
- Parkinson's Disease, Validity, Reability
- Keywords
- parkinson's disease, balance, validity, reability
- Medical subject headings
- Parkinson Disease
What is being measured
The primary outcome is the main question the study is designed to answer.
mini best test
- Mini Best Test Description: This is one of the clinical tests used to assess walking and balance. It consists of four sub-parameters: preparatory movement, reactive postural control, sensory orientation, and dynamic walking, comprising a total of 14 items. It is a test scored out of a total of 28 points, taking an average of 10-15 minutes to complete. A high score indicates high function.
Measured: Measured once, at baseline (Session 1)
Manual muscle testing device
- Manual muscle testing device Description: muscle strength (right foot dorsiflexion, left foot dorsiflexion, right foot plantar flexion, left foot plantar flexion) will be measured using the Commander Echo brand manual muscle testing device. The participant will be a
Measured: Measured once, at baseline (Session 1)
Enhanced Paper Grasping Test
Description: During measurement, participants will sit in a calm environment on a chair without armrests, with their feet and knees at a 90-degree angle, and their upper limbs comfortably placed alongside their torso. This test involves
Measured: Baseline (Session 1) and 1 week later (Session 2)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Aug 2026
- Study start10 Aug 2025
- Primary completion12 Jan 2026
- Study completion25 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson's DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sanko University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hakan Polat, Sanko University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07772622
- Sponsor's protocol ID
- hakanpolat15
- Status last verified
- Feb 2026
- First submitted
- 25 Feb 2026
- Last updated
- 19 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 19 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Validity and Reliability of an Improved Paper Grasping Test for Parkinson's Disease
- ClinicalTrials.gov ID
- NCT07772622
- Acronym / sponsor ID
- hakanpolat15
- Conditions
- Parkinson's Disease, Validity, Reability
- Keywords
- parkinson's disease, balance, validity, reability
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Sanko UniversityUniversity, hospital or other
- Study start
- 10 Aug 2025 (actual)
- Primary completion
- 12 Jan 2026 (actual)
- Study completion
- 25 Jun 2026 (actual)
- First posted
- 19 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study will include volunteer patients diagnosed with Parkinson's disease who applied to the Neurology Outpatient Clinic at SANKO University Sani Konukoğlu Application and Research Hospital.
Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University.
The assessment form prepared by the researchers will be completed face-to-face with the patients. First, demographic information and disease-related data (duration since Parkinson's diagnosis, disease stage, affected side, etc.) will be recorded. The Mini-BESTest will be used to evaluate balance and gait. The muscle strength of the ankle plantar flexor and dorsiflexor muscles will be assessed using a manual muscle testing device, and quality of life will be measured with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Since fall problems in patients may be related to balance impairments, lower limb muscle weakness, and reduced quality of life, these parameters will also be evaluated. Therefore, in this study, while examining the validity and reliability of the modified paper grip test in individuals with Parkinson's disease, its correlation with these parameters will also be investigated.
Before administering the tests, participants will receive a practical explanation of how the tests are performed and will be allowed to rest prior to assessment. The tests will be administered in the following order: first, the paper grip test by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle plantar and dorsiflexor muscle strength, and evaluation of quality of life.
One week after the initial assessment, only the paper grip test will be re-administered by Physiotherapist Fatma Yılmaz in the same environment. This approach will minimize the effect of environmental factors on the patients' performance.
Detailed description
Parkinson's disease is one of the most significant neurodegenerative disorders causing disability worldwide. It is characterized by progressive loss of dopaminergic neurons in the substantia nigra, leading to motor symptoms such as bradykinesia, rigidity, tremor, postural instability, and gait disturbances. Symptoms vary depending on disease stage and the affected neural pathways. Common symptoms observed in individuals with Parkinson's disease include muscle weakness, reduced upper limb function, gait difficulties, balance and coordination impairments, and, in some cases, cognitive and communication problems.
Patients with Parkinson's disease are at high risk of falling, particularly due to balance and postural instability. Consequently, fear of falling can lead to kinesiophobia (fear of movement), decreased engagement in activities of daily living, and difficulties in functional adaptation. Balance problems are among the primary motor deficits in Parkinson's disease and contribute significantly to gait disturbances, postural instability, and fall risk. Therefore, balance rehabilitation is a key focus in the management of Parkinson's disease, especially for fall prevention.
A detailed assessment of balance is essential for planning effective rehabilitation programs. According to the literature, balance evaluation in Parkinson's patients is generally performed using static and dynamic assessments. Commonly used tools include the Mini-BESTest, the Functional Reach Test, and the Timed Up and Go Test (TUG). However, a major contributor to balance problems is lower extremity muscle weakness, particularly in the ankle. While research shows a significant relationship between lower limb muscle weakness and increased fall risk in Parkinson's patients, existing assessment tools often lack direct quantitative measurements, which may reduce their clinical effectiveness.
The Enhanced Paper Grip Test (EPGT) can help address this gap. The EPGT provides a simple measurement of hallux plantar flexion strength without requiring specialized equipment. It can be used to assess fall risk in individuals with Parkinson's disease and has been suggested as a practical screening tool in geriatric populations. The validity and reliability of the test have also been demonstrated in individuals diagnosed with multiple sclerosis. The EPGT is easy to administer, requires minimal space, is low-cost, and quick to perform, making it a practical clinical tool. In this study, the researchers aimed to examine the validity and reliability of the modified paper grip test in Parkinson's patients.
Volunteer patients diagnosed with Parkinson's disease who applied to the SANKO University Sani Konukoğlu Application and Research Hospital Neurology Polyclinic will be included in the study. Patients who meet the inclusion criteria will be evaluated by Dr. Hakan Polat and Physiotherapist Fatma Yılmaz in the application laboratory of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, SANKO University. The role of Associate Professor Zekiye İpek Kırmacı in the study includes planning the study, formulating hypotheses, interpreting the results, and preparing the manuscript for publication.
The assessment form prepared by the researchers will be completed face-to-face with patients. First, demographic information and disease-related data (such as disease duration, affected side, and affected limb) will be recorded. Balance and gait will be assessed using the Mini-BESTest. The muscle strength of the ankle plantar and dorsiflexor muscles will be measured using a manual muscle testing device, and quality of life will be evaluated with the Parkinson's Disease Questionnaire-39 (PDQ-39).
Because fall risk in Parkinson's patients may be related to balance impairments, lower limb muscle weakness, particularly in the ankle, and reduced quality of life, these parameters will also be examined. Therefore, in this study, while evaluating the validity and reliability of the modified paper grip test in Parkinson's patients, its correlation with these parameters will also be investigated.
Before administering the tests, participants will receive a practical explanation of the procedures and will be allowed to rest prior to assessment. The order of testing will be as follows: first, the paper grip test performed by Dr. Hakan Polat, followed by the Mini-BESTest, assessment of ankle muscle strength, and evaluation of quality of life.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 40 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- parkinson
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
mini best test
Time frame: Measured once, at baseline (Session 1)
1. Mini Best Test Description: This is one of the clinical tests used to assess walking and balance. It consists of four sub-parameters: preparatory movement, reactive postural control, sensory orientation, and dynamic walking, comprising a total of 14 items. It is a test scored out of a total of 28 points, taking an average of 10-15 minutes to complete. A high score indicates high function.
Manual muscle testing device
Time frame: Measured once, at baseline (Session 1)
2. Manual muscle testing device Description: muscle strength (right foot dorsiflexion, left foot dorsiflexion, right foot plantar flexion, left foot plantar flexion) will be measured using the Commander Echo brand manual muscle testing device. The participant will be a
Enhanced Paper Grasping Test
Time frame: Baseline (Session 1) and 1 week later (Session 2)
Description: During measurement, participants will sit in a calm environment on a chair without armrests, with their feet and knees at a 90-degree angle, and their upper limbs comfortably placed alongside their torso. This test involves
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Aug 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Parkinson's Disease
Not yet recruiting
Non-invasive Vagus Nerve Stimulation for Parkinson's Disease
Idiopathic Parkinson Disease
RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Parkinsons Disease (PD)
RecruitingPhase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Parkinson's Disease, Dementia
Not yet recruiting
Cognitive-Motor Training for Gait Adaptability in Parkinson Disease
Parkinson Disease
Recruiting
Strength and Dual-Task on Sarcopenia in People With Parkinson's Disease
PARKINSON DISEASE (Disorder), Parkinsonism or Parkinson's Disease Nos
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Parkinson's Disease and Validity, run by Sanko University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
mini best test (time frame: Measured once, at baseline (Session 1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.